Cases & Deals

Celgene develops global patent portfolio for small molecule therapeutics

Clients Celgene Corporation, a Bristol-Myers Squibb company

Jones Day represents Celgene Corporation (now a Bristol-Myers Squibb company) in the establishment of a global patent portfolio related to small molecules for the treatment of cancer and autoimmune disorders.